INCANTHERA LTD has a total of 22 patent applications. Its first patent ever was published in 2008. It filed its patents most often in EPO (European Patent Office), United States and Hungary. Its main competitors in its focus markets pharmaceuticals and biotechnology are ZENSUN SHANGHAI SCI TECH LTD, AURINIA PHARMACEUTICALS INC and TARIX PHARMACEUTICALS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 7 | |
#2 | United States | 6 | |
#3 | Hungary | 3 | |
#4 | Japan | 3 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Loadman Paul | 21 |
#2 | Gill Jason | 18 |
#3 | Patterson Laurence | 15 |
#4 | Bibby Michael | 13 |
#5 | Atkinson Jennifer | 10 |
#6 | Falconer Robert | 8 |
#7 | Xavier Jennifer | 5 |
#8 | Falconer Rob | 5 |
#9 | Falconer Robert Andrew | 5 |
#10 | Rob Falconer | 3 |
Publication | Filing date | Title |
---|---|---|
EP3348282A1 | Mmp activated vascular disrupting agents |